Implementation of National Allergy Council Schools/Childcare project (supported by funding from the Australian government) including the following achievements for activities allocated to ASCIA in 2024:

• Evaluation reports based on feedback surveys (completed by 43,945 users in 2023 and 5,254 users in 2022) from ASCIA anaphylaxis e-training courses for schools, children's education/care and community. www.allergy.org.au/ascia-reports#nacscec
• Development of a new ASCIA Anaphylaxis Training Refresher Video for schools, children's education/care and community, based on feedback from course participants and the content of ASCIA anaphylaxis refresher e-training courses. www.allergy.org.au/ascia-videos
• Ongoing maintenance and support of ASCIA anaphylaxis e-training courses for schools, children's education/care with 2,119 help requests received and resolved in 2023 and 1,058 help requests received and resolved from January to June 2024.

The following projects are due for completion in 2025:

• Evaluation reports based on 2024 feedback surveys in ASCIA anaphylaxis e-training courses for schools, children's education/care and community. 
• Development of a Scoping Report for undergraduate education/training for people studying to work in schools and children's education/care. (Due date extended to March 2025).
• Updating of ASCIA website and e-training learning management system (LMS) to improve the user experience (US) and user interface (UI) for patients, carers, schools, chidren's education/care and community.

Implementation of National Allergy Council Shared Care for Allergy project (supported by funding from the Australian government) including the following achievements for activities allocated to ASCIA in 2024: 

• Funding of 5 health professional education and training initiatives through an EOI process. www.allergy.org.au/national-allergy-strategy
• Evaluation reports based on feedback surveys (completed by 1,730 users in 2023 and 1,176 users in 2022) from ASCIA anaphylaxis e-training courses for health professionals. www.allergy.org.au/ascia-reports#scap
• Updating of more than 100 ASCIA patient/carer educational resources to promote patient/carer organisations and improve readability. www.allergy.org.au/patients
• Improved access to more than 400 ASCIA online education, training and clinical resources through development and promotion of ASCIA Quicklinks. www.allergy.org.au/about-ascia/quick-links
• Participation in 12 medical conferences with more than 14,000 delegates, to promote ASCIA education, training and clinical resources. www.allergy.org.au/ascia-reports#sca
• Increased promotion of ASCIA resources through the ASCIA website, e-newsletters and social media, with a reach of more than 12,000  followers/subscribers each month and more than 3 million website pageviews each year (250,000 each month).
• Application submitted for MBS food challenge item number. www.allergy.org.au/about-ascia/info-updates/ascia-application-for-mbs-item-for-supervised-oral-food-challenges
• Planning for development of an ASCIA referral toolkit. www.allergy.org.au/patients/allergy-and-clinical-immunology-services 
• RACGP accreditation of ASCIA anaphylaxis e-training for health professionals (2025 version).
• Ongoing maintenance of ASCIA e-training courses for health professionals.

The following projects are due for completion in 2025:

• Further accreditation of ASCIA anaphylaxis e-training for health professionals (2025 version)
• Updating of ASCIA health professional educational resources to promote patient/carer organisations. 
• Evaluation reports based on 2024 feedback surveys in ASCIA anaphylaxis e-training courses for health professionals. 
• Development of ASCIA anaphylaxis refresher training video for health professionals, based on feedback from course participants and the content of ASCIA anaphylaxis refresher e-training. 
• Resubmission of application for MBS food challenge item number. (Due March 2025) 
• Development of a Scoping Report for undergraduate education/training for people studying to work as health professionals. (Due date extended to March 2025).
• Updating of ASCIA website and e-training learning management system (LMS) to improve the user experience (US) and user interface (UI) for health professionals.

Implementation of National Allergy Council Drug (Medication) Allergy project (supported by funding from the Australian government)

The following projects are due for completion in 2025:

• Development of new ASCIA Drug (Medication) Allergy etraining course for health professionals.
• Development of other drug allergy resources, working in collaboration with the National Allergy Council.

This news item was issued on 18 November 2024 by Jill Smith, CEO of ASCIA, the peak professional body for clinical immunology and allergy in Australia and New Zealand.